National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

yttrium Y 90 DOTA monoclonal antibody HuAFP31 (IH-tree-um … MAH-noh-KLOH-nul AN-tee-BAH-dee …)

 A substance being studied in the treatment of liver cancer. HuAFP31 is a monoclonal antibody that can locate and bind to tumor cells that make a protein called alpha fetoprotein (AFP). It is linked to a radioactive substance called yttrium Y 90, which may help kill the cancer cells. Yttrium Y 90 DOTA monoclonal antibody HuAFP31 is a type of radioimmunoconjugate.



Previous Definitions:yoga, yohimbe, yttrium, yttrium Y 90, yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A
Next Definitions:yttrium Y 90 DOTA-biotin, yttrium Y 90 DOTA-tyr3-octreotide, yttrium Y 90 edotreotide, yttrium Y 90 ibritumomab tiuxetan, yttrium Y 90 SMT 487

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov